https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
The MONARCA I and II trials were negative but suggested that smartphone-based monitoring may increase quality of life and reduce perceived stress in bipolar disorder (BD). The present trial was the first to investigate the effect of smartphone-based monitoring on the rate and duration of readmissions in BD. This was a randomized controlled single-blind parallel-group trial. Patients with BD (ICD-1 discharged from hospitalization in the Mental Health Services, Capital Region of Denmark were randomized 11 to daily smar
Like
Comment
Share
